J. Lee

1422MO Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-low, advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Results of the exploratory cohorts in the phase II, multicenter, open-label DESTINY-Gastric01 study

Kensei Yamaguchi, Y-J. Bang, Satoru Iwasa et al. · Annals of Oncology · 2020 · 44 citations · Full text

Medicine, Oncology, Surgery +17

1442P Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro + chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062

Lucjan Wyrwicz, Kyung-Woo Lee, Eric Van Cutsem et al. · Annals of Oncology · 2020 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16

164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors

Monica Sharma, Richard D. Carvajal, Glenn J. Hanna et al. · Annals of Oncology · 2021 · 10 citations · Full text

Medicine, Immunology, Oncology +17